Céline Dion is gearing up for her upcoming five-week residency in Paris by sharing more insights into her health struggles and treatment. The renowned Canadian singer revealed in an exclusive interview with Harper’s Bazaar that she experienced symptoms of stiff person syndrome for 17 years before receiving a formal diagnosis of the rare neurological autoimmune disorder in 2022.
The pain intensified in 2020, to the point where she struggled to walk on some days and required a high dosage of Valium to manage the discomfort. Stiff person syndrome is a progressive condition that worsens over time, affecting only one or two individuals per million. Symptoms may involve muscle rigidity and painful spasms triggered by stress, loud noises, or sudden movements. Although there is no known cause or approved treatment for the condition, various therapies can help alleviate its effects.
Before her diagnosis, Dion would attribute show cancellations to minor ailments like coughs or sinus infections, concealing the true extent of her suffering. She expressed feeling a sense of dishonesty towards her fans, whose unwavering support enabled her to seek extensive treatment.
Following her diagnosis, Dion halted all performances but is now preparing for her return to the stage in September. Her recovery routine includes a combination of medication, physical therapy, vocal therapy, and immunotherapy. Additionally, she dedicates herself to 90-minute Pilates sessions thrice weekly and ballet classes twice a week to prepare for her upcoming shows.
Describing Dion as constantly on the move, reporter Jazmine Hughes highlighted in the Harper’s feature how the singer fears becoming immobile if she stays still for too long. Dion views her recovery and potential comeback as a miraculous opportunity she deeply values.
Looking ahead with a mix of strength, excitement, and nerves, Dion is set to kick off her Paris residency, featuring 26 concerts from September 12 to May 29 next year.